Tarah Ballinger
IUSCCC · Indiana University · Indiana University School of Medicine, Indiana University Simon Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Tarah Ballinger as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:08 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07825454 · Pilot Study of Hydroxychloroquine for the Treatment of AIMSSIndiana University · recruiting · Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS), Joint Pain, Breast Cancer · principal investigator
- N/ANCT05468034 · Exercise in Metastatic Breast Cancer: EMBodyIndiana University · recruiting · Breast Cancer, Indolent Metastatic Breast Cancer · principal investigator
- N/ANCT05062174 · Breast Cancer BRCA1 Carriers: a Pilot StudyIndiana University · withdrawn · BRCA1 Mutation, High-grade Serous Ovarian Cancer, TNBC - Triple-Negative Breast Cancer · principal investigator
- N/ANCT04170920 · Pilot Study of a an App to Improve Medication Adherence in Breast Cancer Survivors Receiving AIsIndiana University · completed · Breast Cancer, DCIS · principal investigator
- N/ANCT04047589 · Assessing Exercise Behavior and Preferences Among Patients and OncologistsIndiana University · completed · Solid Tumor, Exercise · principal investigator
- N/ANCT03712813 · Effect of Low Intensity Vibration (LIV) on Aromatase Inhibitor- Induced Musculoskeletal Dysfunction in Early Stage Breast Cancer SurvivorsIndiana University · completed · Breast Cancer · principal investigator
- N/ANCT03581552 · Effects of Aromatase Inhibitor Therapy on Muscle FunctionTarah J Ballinger, MD · completed · Breast Cancer, Breast Cancer Female · principal investigator
- N/ANCT02681120 · Pilot Study of the Effect of Weight Loss on Breast Tissue and Blood Biomarkers in Women at Increased Risk for Breast CancerTarah J Ballinger, MD · completed · Breast Neoplasms, Obesity · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:08 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name in breast cancer, ranked by citations from NIH iCite, fetched 2026-11-12 11:08 UTC. The ranking covers the 200 most relevant of 13 PubMed records, and a shared surname and initials can bring in a namesake. All 13 on PubMed
- TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes.J Clin Oncol · 2020417 citationsRCR 15.8
- 267 citationsRCR 11.0
- 48 citationsRCR 2.7
- Inhibiting Fatty Acid Synthase with Omeprazole to Improve Efficacy of Neoadjuvant Chemotherapy in Patients with Operable TNBC.Clin Cancer Res · 202142 citationsRCR 2.2
- Subcutaneous vs Intravenous Trastuzumab/Pertuzumab: A Time and Motion Substudy of a Phase II Trial of Adjuvant Trastuzumab/Pertuzumab for Stage I HER2+ Breast Cancer (ADEPT trial).JCO Oncol Pract · 202516 citationsRCR 3.9
- 13 citationsRCR 0.6
- Impact of Muscle Measures on Outcome in Patients Receiving Endocrine Therapy for Metastatic Breast Cancer: Analysis of ECOG-ACRIN E2112.J Natl Compr Canc Netw · 202310 citationsRCR 0.9
- Abdominal visceral and subcutaneous adipose tissue associations with postmenopausal breast cancer incidence.JNCI Cancer Spectr · 20257 citationsRCR 1.3
- Randomized Controlled Trial of Acceptance and Commitment Therapy for Fatigue Interference With Functioning in Metastatic Breast Cancer.J Clin Oncol · 20256 citationsRCR 2.0
- Impact of Body Mass Index on Presence of ctDNA and Disease Recurrence after Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer: Analysis from BRE12-158.Clin Cancer Res · 20215 citationsRCR 0.3